Low-Energy laser shows promise for early AMD vision preservation
NCT ID NCT07554690
First seen Apr 28, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tests a non-invasive laser treatment called photobiomodulation (PBM) in 67 people with early age-related macular degeneration (AMD) who have reticular pseudodrusen. The laser uses specific light wavelengths to stimulate cells and reduce inflammation. Half the participants get the real treatment, half get a fake one. The goal is to see if PBM can slow vision loss and improve sight in low light over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMD - AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Fondazione G.B.Bietti c/o Ospedale Britannico
Roma, Italy, 00184, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.